New research reveals that patients with coronary artery disease who were treated with a drug designed to increase HDL or good cholesterol levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo. The research was conducted by the Cleveland Clinic Coordinating Center for Clinical Research (C5Research). The drug, RVX-208, induces the production of apolipoprotein A1 (apoA1), a major protein in HDL. Prior research has ...You have just read an article categorized health
titled Drug to Increase Good Cholesterol Shows No Benefit Over Placebo in ASSURE Trial.
Written by:
editor - Thursday, September 5, 2013
There are currently no comments for "Drug to Increase Good Cholesterol Shows No Benefit Over Placebo in ASSURE Trial"
Post a Comment